This inventor holds 3 USPTO granted patents. Top assignees: Ipsen Pharma S.a.s., Société De Conseils De Recherches Et D'applications Scientifiques, S.a.s., Societe De Conseils De Recherches Et D'applications Scientifiques Sas. Active years: 2003-2009.
Company Filing History:
1 out of 108 
1 out of 1 
1 out of 47 Years Active: 2003-2009
Title: Dennis C H Bigg: Innovator in Imidazolyl Derivatives
Introduction
Dennis C H Bigg is a notable inventor based in Gif sur Yvette, France. He has made significant contributions to the field of pharmaceuticals, particularly through his work on imidazolyl derivatives. With a total of 3 patents to his name, Bigg's innovations have the potential to impact medical science.
Latest Patents
Bigg's latest patents focus on imidazolyl derivatives, specifically those of formula (I). These compounds are designed to act as agonists or antagonists of somatostatin receptors, which play a crucial role in various physiological processes. The detailed specifications of these derivatives highlight their potential therapeutic applications.
Career Highlights
Throughout his career, Dennis C H Bigg has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Société De Conseils De Recherches Et D'applications Scientifiques, S.a.s. and Ipsen Pharma S.a.s. His work in these organizations has contributed to advancements in drug development and research.
Collaborations
Bigg has collaborated with esteemed colleagues, including Christophe Thurieau and Lydie Francine Poitout. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
Dennis C H Bigg is a distinguished inventor whose work on imidazolyl derivatives showcases his commitment to advancing pharmaceutical science. His contributions are expected to have lasting effects in the field.